Abbott Laboratories (ABT) Balance Sheet

NYSE: ABTAssets, liabilities, debt and equity over 10 years.

ABT balance sheet, 2025

December 31, 2025 · U.S. dollars

$86.71B assets = $33.94B liabilities + $52.77B equity

What it owns$86.71BCash & ST investments: $8.94B (10.3%)$8.94BReceivables: $7.93B (9.1%)Receivables $7.93BInventory: $6.49B (7.5%)Inventory $6.49BOther current: $2.64B (3.0%)PP&E: $12.94B (14.9%)PP&E$12.94B · 15%Goodwill & intangibles: $29.56B (34.1%)Goodwill & intangibles$29.56B · 34%LT investments: $918.0M (1.1%)Other non-current: $17.30B (19.9%)Other non-current$17.30B · 20%=How it is financed$86.71BCurrent liabilities: $16.50B (19.0%)Current liabilities$16.50B · 19%Long-term debt: $9.90B (11.4%)Long-term debt $9.90BOther LT liabilities: $7.55B (8.7%)$7.55BShareholders’ equity: $52.77B (60.9%)Shareholders’ equity$52.77B · 61%

Both columns are drawn to the same scale: what ABT owns equals what it owes plus shareholders’ equity. Hover a block for its value.

ABT financial health

Current ratio1.58
Comfortable · current assets cover current liabilities 1.58×
Debt / equity0.29
Low leverage · $0.29 of debt for each $1 of equity
Equity / assets60.1%
Equity-funded · of assets funded by shareholders
Cash / debt59.3%
Partial cover · cash & short-term investments vs total debt
Goodwill & intangibles34.1%
Acquisition-heavy · of total assets

Descriptive bands, not a rating. Fiscal 2025.

ABT balance sheet trends, 2016–2025

Abbott Laboratories balance sheet trends
MetricTrendThenLatestChange
Total assets$55.01B2016$86.71B2025+5.2%/yr
Total liabilities$31.95B2016$33.94B2025+0.7%/yr
Shareholders’ equity$20.54B2016$52.13B2025+10.9%/yr
Cash & short-term investments$18.77B2016$8.94B2025−7.9%/yr
Total debt$22.01B2016$15.07B2025−4.1%/yr
Net cash (debt)−$3.23B2016−$6.13B2025−$2.9B
Working capital$20.12B2016$9.50B2025−$10.6B
Book value per share$13.852016$29.842025+8.9%/yr
Current ratio4.0220161.582025−2.44
Debt / equity1.0720160.292025−0.78
Shares outstanding1.48B20161.75B2025+1.8%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

ABT assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

ABT liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

ABT debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

ABT balance sheet

Abbott Laboratories annual balance sheet
2025202420232022202120202019201820172016
Assets
Cash & short-term investments$8.94B$7.97B$7.28B$10.17B$10.25B$7.15B$4.14B$4.09B$9.61B$18.77B
Cash & equivalents$8.52B$7.62B$6.90B$9.88B$9.80B$6.84B$3.86B$3.84B$9.41B$18.62B
Short-term investments$417.0M$351.0M$383.0M$288.0M$450.0M$310.0M$280.0M$242.0M$203.0M$155.0M
Receivables$7.93B$6.92B$6.57B$6.22B$6.49B$6.41B$5.42B$5.18B$5.25B$3.25B
Inventory$6.49B$6.19B$6.57B$6.17B$5.16B$5.01B$4.32B$3.80B$3.60B$2.43B
Other current assets$2.64B$2.57B$2.26B$2.66B$2.35B$1.87B$1.79B$1.57B$1.69B$2.32B
Total current assets$26.00B$23.66B$22.67B$25.22B$24.24B$20.44B$15.67B$14.63B$20.15B$26.78B
Property, plant & equipment (net)$12.94B$11.73B$11.28B$10.28B$10.11B$10.13B$8.97B$7.56B$7.61B$5.71B
Goodwill & intangible assets$29.56B$29.75B$32.49B$33.25B$35.97B$38.53B$40.22B$42.20B$45.49B$12.22B
Long-term investments$918.0M$886.0M$799.0M$766.0M$816.0M$821.0M$883.0M$897.0M$883.0M$2.95B
Other non-current assets$17.30B$15.38B$5.97B$4.92B$4.06B$2.63B$2.15B$1.89B$2.12B$7.36B
Total assets$86.71B$81.41B$73.21B$74.44B$75.20B$72.55B$67.89B$67.17B$76.25B$55.01B
Liabilities
Accounts payable$4.24B$4.20B$4.29B$4.61B$4.41B$3.95B$3.25B$2.98B$2.40B$1.18B
Short-term debt$3.31B$1.75B$1.32B$2.48B$999.0M$461.0M$1.68B$207.0M$714.0M$1.32B
Deferred revenue——$174.0M————$305.0M$309.0M$188.0M
Total current liabilities$16.50B$14.16B$13.84B$15.49B$13.11B$11.91B$10.86B$9.01B$8.91B$6.66B
Long-term debt$9.90B$12.62B$13.60B$14.52B$17.30B$18.53B$16.66B$19.36B$27.21B$20.68B
Lease obligations$931.0M$896.0M$949.0M$943.0M$956.0M$902.0M$755.0M———
Other long-term liabilities$7.55B$6.73B$6.95B$7.52B$8.77B$9.11B$9.06B$8.08B$9.03B$6.95B
Total liabilities$33.94B$33.51B$34.39B$37.53B$39.17B$39.55B$36.59B$36.45B$45.15B$31.95B
Shareholders' equity
Common stock & paid-in capital$25.53B$25.15B$24.87B$24.71B$24.47B$24.14B$23.85B$23.51B$23.21B$13.03B
Retained earnings (deficit)$49.78B$47.26B$37.55B$35.26B$31.53B$27.63B$25.85B$24.56B$23.98B$25.57B
Treasury stock————−$11.82B−$10.04B−$10.15B−$9.96B−$10.22B−$10.79B
Accumulated other comprehensive income−$6.00B−$7.91B−$7.84B−$8.05B−$8.37B−$8.95B−$8.46B−$7.59B−$6.06B−$7.26B
Minority interest$641.0M$237.0M$224.0M$219.0M$222.0M$219.0M$213.0M$198.0M$201.0M$179.0M
Total shareholders' equity$52.13B$47.66B$38.60B$36.69B$35.80B$32.78B$31.09B$30.52B$30.90B$20.54B
Key figures
Total debt$15.07B$15.28B$15.87B$17.95B$19.25B$19.89B$19.10B$19.57B$27.92B$22.01B
Net cash (debt)−$6.13B−$7.31B−$8.59B−$7.78B−$9.00B−$12.74B−$14.96B−$15.48B−$18.31B−$3.23B
Working capital$9.50B$9.50B$8.83B$9.73B$11.13B$8.53B$4.80B$5.62B$11.23B$20.12B
Tangible book value$22.57B$17.91B$6.11B$3.43B−$168.0M−$5.74B−$9.13B−$11.67B−$14.60B$8.32B
Book value per share$29.84$27.27$22.07$20.80$20.01$18.36$17.46$17.25$17.67$13.85
Shares outstanding1.75B1.75B1.75B1.76B1.79B1.79B1.78B1.77B1.75B1.48B
Current ratio1.581.671.641.631.851.721.441.622.264.02
Quick ratio1.021.051.001.061.281.140.881.031.673.31
Debt / equity0.290.320.410.490.540.610.610.640.901.07
Equity / assets60.1%58.5%52.7%49.3%47.6%45.2%45.8%45.4%40.5%37.3%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 20, 2026); data from EODHD.

ABT financial position

At the end of fiscal 2025 (December 31, 2025), Abbott had total assets of $86.7 billion (up 6.5% from a year earlier), total liabilities of $33.9 billion and shareholders' equity of $52.1 billion. It held $8.9 billion in cash and short-term investments against $15.1 billion of debt, net debt of $6.1 billion. Its current ratio was 1.58. In the latest quarter (ended June 30, 2026) total assets were $109.2 billion and equity $51.1 billion.

Related: ABT income statement, ABT cash flow statement, ABT key metrics. See the ABT stock overview for the latest quote and news.

ABT balance sheet FAQ

What are Abbott's total assets?

Abbott reported total assets of $86.7 billion at the end of fiscal 2025 (December 31, 2025), compared with $81.4 billion a year earlier.

How much debt does Abbott have?

Abbott had $15.1 billion of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.29.

How much cash does Abbott have?

Abbott held $8.9 billion in cash and short-term investments at the end of fiscal 2025; with $15.1 billion of debt that is net debt of $6.1 billion.

What is Abbott's book value?

Abbott's shareholders' equity (book value) was $52.1 billion at the end of fiscal 2025, or $29.84 per share.

What is Abbott's current ratio?

Abbott had current assets of $26.0 billion and current liabilities of $16.5 billion, a current ratio of 1.58 (it can cover its short-term obligations).

How much goodwill does Abbott have?

Abbott carried $29.6 billion of goodwill and intangible assets, 34.1% of total assets, at the end of fiscal 2025.

Medical Devices: balance sheet